Saturday, September 26, 2026
MiningNewsTerminal
Saturday, September 26, 2026 Admin

IFOS.V ·

Itafos Reports Outstanding Operational and Financial Q4 and FY 2024 Results

Financials

1

TSX-V: IFOS

News Release

ITAFOS REPORTS OUTSTANDING OPERATIONAL AND FINANCIAL Q4 AND FY 2024 RESULTS

HOUSTON, TX – March 19, 2025 – Itafos Inc. (TSX-V: IFOS) (the “Company”) today reported its Q4 2024 and full year 2024 financial

results and provided a corporate update. The Company’s financial statements and management’s discussion and analysis for the three

months and year ended December 31, 2024 are available under the Company’s profile at www.sedarplus.ca and on the Company’s

website at www.itafos.com. All figures are in thousands of US Dollars except as otherwise noted.

CEO Commentary

Chief Executive Officer David Delaney commented, “2024 marked another year of outstanding performance from both operational a nd

financial perspectives. Conda production exceeded 2023 production levels, despite an additional 12 days of planned maintenanc e and

at Arraias sulfuric acid production increased by 26.6% compared to last year. This was achieved while maintaining our culture of safety,

recording a TRIFR for the year of 0.89. These factors allowed us to record revenues of $491.2 million and adjusted E BITDA1 of $159.5

million, increases of 6% and 21% compared to 2023, respectively.

Looking forward, we expect our mine life extension program at Husky 1 / North Dry Ridge to deliver first ore shipments to the Conda plant

in the second half of 2025. This year we have actively commenced work on identifying incremental opportunities to exte nd our mining

operations in Southeast Idaho to take advantage of the abundant phosphate resources in the basin where we operate. These nea rfield

opportunities have the potential to provide further utilization of the H1/NDR infrastructure.

We are committed to creating long-term shareholder value, and following the sale of the Araxa project we are pleased to announce that

our Board of Directors has approved a CAD$0.05 per share special dividend payable on April 25, 2025 with a record date of April 9, 2025.

The Board continues to evaluate all alternatives to return capital to our shareholders considering current fertilizer markets , future capital

requirements and the overall financial liquidity of the company. The special dividend has been made possible by the sale of our non-core

Araxa asset and our continued success in generating cash from our operations, all while reducing our net debt and increasing our financial

liquidity.”

Q4 2024 Financial Highlights

For Q4 2024, the Company’s financial highlights were as follows:

▪ Revenues of $138.2 million in Q4 2024 compared to $119.0 million in Q4 2023;

▪ Adjusted EBITDA1 of $45.5 million in Q4 2024 compared to $29.5 million in Q4 2023;

▪ Net income of $29.6 million in Q4 2024 compared to $(48.6) million in Q4 2023;

▪ Basic earnings of C$0.22/share in Q4 2024 compared to C$(0.35)/share in Q4 2023; and

▪ Free cash flow1 of $17.1 million in Q4 2024 compared to $4.7 million in Q4 2023.

The increase in the Company’s Q4 2024 financial performance compared to the corresponding period in the prior year was primarily due

to higher realized prices and higher sales volumes at Conda.

The Company’s total capex1 spend in Q4 2024 was $13.5 million compared to $21.2 million in Q4 2023 with the decrease primarily due

to the timing of development activities spend at H1/NDR.

FY 2024 Financial Highlights

For FY 2024, the Company’s financial highlights were as follows:

▪ Revenues of $491.2 million in FY 2024 compared to $465.5 million in FY 2023;

▪ Adjusted EBITDA of $159.5 million in FY 2024 compared to $131.8 million in FY 2023;

▪ Net income of $87.8 million in FY 2024 compared to $3.1 million in FY 2023;

▪ Basic earnings of C$0.63/share in FY 2024 compared to C$0.02/share in FY 2023; and

▪ Free cash flow of $54.8 million in FY 2024 compared to $41.4 million in FY 2023.

1Adjusted EBITDA, free cash flow and total capex are each a non-International Financial Reporting Standards (“IFRS”) financial measure. The Company

reports non-IFRS financial measures to manage and evaluate its business. See “Non -IFRS Financial Measures” section below for more information on

non-IFRS measures and a reconciliation to the most comparable IFRS financial measures.

2

The increase in the Company’s FY 2024 financial performance compared to FY 2023 was primarily due to higher realized prices at Conda

and higher sulfuric acid and dry product sales at Arraias, which were partially offset by slightly lower sales volumes at Conda which are

a result of the planned large scope turnaround at Conda in Q2 2024.

The Company’s total capex spend in FY 2024 was $71.2 million compared to $58.4 million in FY 2023 with the increase primarily due to

development activities at H1/NDR and the large scope turnaround at Conda, as well as the sulfuric acid plant turnaround at Arraias.

As of December 31, 2024, the Company’s financial highlights were as follows:

▪ Trailing 12 months Adjusted EBITDA2 of $159.5 million

▪ Net debt2 of $26.8 million; and

▪ Net leverage ratio2 of 0.2x.

Recent Developments

Sale of the Araxá Project

On August 5, 2024, the Company entered into an agreement to sell its 100% interest in the Araxá project to a wholly -owned subsidiary

of St George Mining Limited (“St George”) (ASX: SGQ) in exchange for a cash payment of $21 million and securities of St George (the

“Transaction”). As a result of the Transaction, St George indirectly acquired all of the outstanding securities of Itafos Ara xá Mineração e

Fertilizantes S.A (“Itafos Araxá”). The Transaction closed on February 26, 2025.

Special Dividend

The Board of Directors has approved a CAD$0.05 per share special dividend payable on April 25, 2025 to shareholders of record as of

the close of business on April 9, 2025. Shareholders should contact their respective brokers or intermediaries for the appro priate tax

election forms regarding this dividend. Shareholders may elect to receive their dividend in Canadian or U.S. dollars by conta cting their

broker or, where applicable, TSX Trust Company, the Company’s registrar and transfer agent.

Exploration and Appraisal Program at Conda

As capital work at H1/NDR continues with first ore shipments expected in 2H 2025, the Company is focused on identifying and pursuing

opportunities to add additional resources and reserves to the project to extend the mine life beyond the current estimate of mid-2037. To

pursue this objective, the Company has commenced a multi-year exploration, resource evaluation and permitting program at Conda with

an expected annual cost of approximately $6-8 million.

The program is focused on further delineating upside potential of the Husky 1 Lease through resource delineation appraisal drilling at

250ft spacing (current spacing at 500ft), delineation drilling on the Dry Ridge Lease on 2000’ centers to gain crucial geolog ic and

metallurgical information to be used in resource modeling that will drive future mine planning resource estimation and permitting baseline

studies, and core drilling and geologic modeling of the Husky 3 and 4 Leases permits to identify resource potential for futur e mine

development along the current mine trend.

In addition to these activities, work will commence on baseline resource studies required for future NEPA permitting and regulatory

approvals. These near field opportunities have the potential to extend the mine life beyond the current NI 43-101 estimate of mid 2037 in

an efficient manner with the objective of utilizing the current infrastructure being built out at H1/NDR.

2Trailing 12 months Adjusted EBITDA, net debt and net leverage ratio are each a non-IFRS financial measure. See “Non-IFRS Financial Measures” section

below for more information on non-IFRS measures and a reconciliation to the most comparable IFRS financial measures.

3

FY 2024 Market and Financial Outlook

Market Outlook

Phosphate pricing decreased marginally in Q4 2024 consistent with seasonal factors. This followed a strong rebound in pricing in late Q2

/ Q3 2024 that began with an early summer reset. Domestic MAP prices have moved off highs achieved during the second half of the

year, while DAP prices have remained relatively firm, bringing the products close to parity. Global phosphat e prices have remained

consistent since the middle of 2024 and remain constructive compared to historical levels.

Crop fundamentals improved over the past quarter, however, uncertainty around the impact of tariffs with US trading partners has seen

increased volatility and recent price declines. The United States Department of Agriculture reduced its estimates for ending stocks for

corn and soybeans based on lower yields and total production. Global inventories of grains and oilseeds outside of China are expected

to decrease over the course of the current crop year, resulting in a declining stock to use ratio that is projected to fall near a 20-year low.

Moving forward, the Company expects relatively flat phosphate pricing through 2025, with risk to the upside supported by the following

factors:

▪ low inventory levels in the North American market and continued strength in global demand; and

▪ ongoing export restrictions from China.

Financial Outlook

The Company’s guidance for 2025 is as follows:

(in millions of US Dollars Projected

except as otherwise noted) FY 2025

Sales Volumes (thousands of tonnes P2O5)3 340-360

Corporate selling, general and administrative expenses4 $17-20

Maintenance capex4 $13-23

Growth capex4 $63-83

Environmental and asset retirement obligations payments $5-7

Q4 and FY 2024 Market Highlights

MAP New Orleans (“NOLA”) prices averaged $623/st in Q4 2024 compared to $614/st in Q4 2023, up 1% year-over-year, and averaged

$610/st in FY 2024 compared to $574/st in FY 2023, up 6% year-over-year.

Specific factors driving the year-over-year increase in MAP NOLA prices were as follows:

▪ limited supply due to weather in the Southeast US impacting phosphate producers;

▪ continuing export restrictions from China; and

▪ an increase in US exports and a decrease in imports.

December 31, 2024, Highlights

As of December 31, 2024, the Company had trailing 12 months Adjusted EBITDA of $159.5 million compared to $131.8 million at the end

of 2023 with the increase primarily due to the same factors that resulted in higher Adjusted EBITDA.

As of December 31, 2024, the Company had net debt of $26.8 million compared to $61.3 million at the end of 2023 , with the reduction

primarily due to higher cash and cash equivalents, which was partially offset by higher debt due to the refinancing in Q3 2024 . The

Company’s net debt as of December 31, 2024 was comprised of $74.4 million in cash and $101.2 million in debt (gross of deferred

financing costs). As at December 31, 2024 and the end of 2023, the Company’s net leverage ratio was 0.2x

As of December 31, 2024, the Company had liquidity 5 of $154.4 million comprised of $74.4 million in cash and $80 million in undrawn

borrowing capacity under its $80 million asset-based revolving credit facility.

3Sales volumes reflect quantity in P2O5 of Conda sales projections

4Corporate selling, general and administrative expenses; maintenance capex, and growth capex are each a non-IFRS financial measure. See “Non-IFRS

Financial Measures” section below for more information on non-IFRS measures and a reconciliation to the most comparable IFRS financial measures.

5Liquidity is a non-IFRS financial measure. For additional information on non-IFRS and other financial measures, see “Non-IFRS financial measures”

below.

4

Operations Highlights and Mine Development

Environmental, Health, and Safety (“EHS”)

▪ For Q4 2024, strong EHS performance, including no reportable environmental releases and one recordable incident, which

resulted in a consolidated total recordable incident frequency rate (“TRIFR”) of 0.89.

▪ For FY 2024, strong EHS performance, including no reportable environmental releases and nine recordable incidents, which

resulted in a consolidated TRIFR of 0.89.

Conda

In Q4 2024, Conda

▪ Produced 97,307 tonnes P2O5 compared to 95,719 tonnes P2O5 in Q4 2023 with the increase driven by production efficiencies

resulting from the successful large scope turnaround maintenance completed in Q2 2024;

▪ Generated revenues of $132.4 million compared to $112.4 million in Q4 2023 with the increase primarily due to higher realized

prices resulting from improved market dynamics and higher sales volumes; and

▪ Generated Adjusted EBITDA of $48.7 million compared to $32.4 million in Q4 2023 with the increase primarily due to higher

cash margin per tonne P2O5.

In FY 2024, Conda:

▪ Produced 349,396 tonnes P2O5 compared to 349,030 tonnes P2O5 in FY 2023 despite an additional 14 days of planned downtime

in 2024 due to the large scope turnaround maintenance. The success of the turnaround maintenance drove higher recoveries,

reduced downtime, and correspondingly higher throughput;

▪ Generated revenues of $467.8 million compared to $448.1 million in FY 2023 with the increase primarily due to higher realized

prices resulting from improved market dynamics, partially offset by the discontinuation of APP in Q2 2024; and

▪ Generated Adjusted EBITDA of $170.1 million compared to $148.1 million in FY 2023 with the increase primarily due to higher

cash margin per tonne P2O5.

Arraias

In Q4 2024, Arraias:

▪ Produced 25,267 tonnes of sulfuric acid compared to 34,087 tonnes in Q4 2023 with the decrease primarily due to short

turnaround taking place in November 2024;

▪ Produced 1,635 tonnes P2O5 of Direct Application Phosphate Rock (“DAPR”) and Partially Acidulated Phosphate Rock (“PAPR”)

compared to 643 tonnes P2O5 in Q4 2023, with the increase due to the full quarter of DAPR and PAPR production and sales per

Fertilizer Restart Program; and

▪ Generated Adjusted EBITDA of $0.8 million compared to $1.1 million in Q4 2023 with the decrease primarily due to lower sulfuric

acid production and sales volume, which were partially offset by sulfuric acid gross margin improvement and positive contribution

from the start of PAPR sales in 2024.

In FY 2024, Arraias:

▪ Produced 112,785 tonnes of sulfuric acid compared to 89,075 tonnes in FY 2023 with the increase due to higher customer

demand and acid consumption with the start of PAPR production;

▪ Produced 18,147 tonnes P 2O5 of DAPR and PAPR compared to 5,196 tonnes P 2O5 in FY 2023, with the increase due to the

launch of PAPR sales in 2024; and

▪ Generated Adjusted EBITDA of $4.3 million compared to $0.4 million in FY 2023 with the increase due to higher sulfuric acid

sales volumes and the launch of PAPR sales in 2024.

5

About Itafos

The Company is a phosphate and specialty fertilizer company. The Company’s businesses and projects are as follows:

▪ Conda – a vertically integrated phosphate fertilizer business located in Idaho, US, with the following production capacity:

- approximately 550kt per year of MAP, MAP with micronutrients (“MAP+”), superphosphoric acid (“SPA”), merchant grade

phosphoric acid (“MGA”) and ammonium polyphosphate (“APP”)

- approximately 27kt per year of hydrofluorosilicic acid (“HFSA”)

▪ Arraias – a vertically integrated phosphate fertilizer business located in Tocantins,Brazil, with the following production capacity:

- approximately 500kt per year of single superphosphate (“SSP”) and SSP with micronutrients (“SSP+”)

- approximately 40kt per year of excess sulfuric acid (220kt per year gross sulfuric acid production capacity)

▪ Farim – a high-grade phosphate mine project located in Farim, Guinea-Bissau and

▪ Santana – a vertically integrated high-grade phosphate mine and fertilizer plant project located in Pará, Brazil.

The Company is a Delaware corporation headquartered in Houston, Texas. The Company’s shares trade on the TSX-V under the ticker

“IFOS”. The Company’s principal shareholder is CL Fertilizers Holding LLC (“CLF”) . CLF is an affiliate of global private investment firm

Castlelake, L.P.

For more information, or to join the Company’s mailing list, please visit www.itafos.com.

Forward-Looking Information

Certain information contained in this news release constitutes forward -looking information, including statements with respect to: the

Company’s planned operations and strategies; the timing for the commencement of operations, infrastructure and civil works at H1 / NDR;

the expected resource life of H1 / NDR; exploration activities to extend mine life; and economic and market trends with respect to the

global agriculture and phosphate fertilizer markets. All information other than information of historical fact is forward-looking information.

Statements that address activities, events or developments that the Company believes, expects or anticipates will or may occu r in the

future include, but are not limited to, statements regarding estimates and/or assumptions in respect of the Company’s financial and

business outlook are forward-looking information. The use of any of the words “intend”, “anticipate”, “plan”, “continue”, “estimate”, “expect”,

“may”, “will”, “project”, “should”, “would”, “believe”, “predict” and “potential” and similar expressions are intended to identify forward-looking

information.

The forward-looking information contained in this news release is based on the opinions, assumptions and estimates of management set

out herein, which management believes are reasonable as at the date the statements are made. Those opinions, assumptions an d

estimates are inherently subject to a variety of risks and uncertainties and other known and unknown factors that could cause actual

events or results to differ materially from those projected in the forward -looking information. These include the Company ’s expectations

and assumptions with respect to the following: commodity prices; operating results; safety risks; changes to the Company’s mi neral

reserves and resources; risk that timing of expected permitting will not be met; changes to mine development and completion; foreign

operations risks; changes to regulation; environmental risks; the impact of weather and climate change; risks related to asse t retirement

obligations, general economic changes, including inflation and foreign exchange rates; the act ions of the Company’s competitors and

counterparties; financing, liquidity, credit and capital risks; the loss of key personnel; impairment risks; cybersecurity ri sks; risks relating

to transportation and infrastructure; changes to equipment and suppliers; concentration risks, adverse litigation; changes to permitting

and licensing; geo-political risks; loss of land title and access rights; changes to insurance and uninsured risks; the potential for malicious

acts; market and stock price volatility; changes to technology, innovation or artificial intelligence; changes to tax laws; the risk of operating

in foreign jurisdictions; the risks posed by a controlling shareholder and other conflicts of interest; risks related to repu tational damage,

the risk associated with epidemics, pandemics and public health; the risks associated with environmental justice; and any risks related to

internal controls over financial reporting risks. Readers are cautioned that the foregoing list of risks, uncertainties and assumptions is not

exhaustive.

Although the Company has attempted to identify crucial factors that could cause actual actions, events or results to differ materially from

those described in the forward -looking information, there may be other factors that cause actions, events or results not to be as

anticipated, estimated or intended. Additional risks and uncertainties affecting the forward -looking information contained in this news

release are described in greater detail in the Company’s Annual Information Form and current Management’s Discussion and Analysis

available under the Company’s profile on SEDAR+ at www.sedarplus.ca and on the Company’s website at www.itafos.com. There can

be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from

those anticipated in such information. The reader is cautioned not to place undue reliance on forward-looking information. The Company

undertakes no obligation to update forward -looking statements if circumstances or management’s estimates, assumptions or opinions

should change, except as required by applicable securities law. The forward-looking information included in this news release is expressly

qualified by this cautionary statement and is made as of the date of this news release.

This news release contains future-oriented financial information and financial outlook information (together, “FOFI”) about the Company’s

prospective results of operations, including statements regarding expected Adjusted EBITDA, net income, basic earnings per share,

maintenance capex, growth capex and free cash flow. FOFI is subject to the same assumptions, risk factors, limitations and qualifications

as set forth in the above paragraph. The Company has included the FOFI to provide an outlook of management’s expectations regarding

anticipated activities and results, and such information may not be appropriate for other purposes. The Company and managemen t

believe that the FOFI has been prepared on a reasonable basis, reflecting management’s reasonable estim ates and judgements;

6

however, actual results of operations and the resulting financial results may vary from the amounts set forth herein. Any financial outlook

information speaks only as of the date on which it is made and the Company undertakes no obligation to publicly upda te or revise any

financial outlook information except as required by applicable securities laws.

NEITHER THE TSX-V NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX-

V) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.

Contacts:

For Investors:

Matthew O’Neill

Executive Vice President & Chief Financial Officer

[email protected]

713-242-8446

For Media:

Alliance Advisors IR

Fatema Bhabrawala

Director, Media Relations

[email protected]

647-620-5002

Scientific and Technical Information

The scientific and technical information contained in this news release related to Mineral Resources for Conda has been revie wed and

approved by Jerry DeWolfe, Professional Geologist (P.Geo.) with the Association of Professional Engineers and Geoscientists of Alberta.

Mr. DeWolfe is a full -time employee of WSP Canada Inc. and is independent of the Company. The scientific and technical information

contained in this news release related to Mineral Reserves for Conda has been reviewed and approved by Terry Kremmel, Professional

Engineer (P.E.) licensed by the States of Missouri and North Carolina. Mr. Kremmel is a full -time employee of WSP USA, Inc. and is

independent of the Company. The Company’s latest technical report in respect of Conda is entitled, “NI 43 -101 Technical Report Itafos

Conda Project, Idaho, USA,” with an effective date of July 1, 2023 and is available under the Company’s website at www.itafos.com and

under the Company’s profile on SEDAR+ at www.sedarplus.ca.

Non-IFRS Financial Measures

This press release contains both IFRS and certain non -IFRS measures that management considers to evaluate the Company’s

operational and financial performance. Non-IFRS measures are a numerical measure of a company’s performance, that either include or

exclude amounts that are not normally included or excluded from the most directly comparable IFRS measures. Management believes

that the non-IFRS measures provide useful supplemental information to investors, analysts, lenders and others. In evaluating non -IFRS

measures, investors, analysts, lenders and others should consider that non-IFRS measures do not have any standardized meaning under

IFRS and that the methodology applied by the Company in calculating such non -IFRS measures may differ among companies and

analysts. Non-IFRS measures should not be considered as a substitute for, nor superior to, measures of financial performance prepared

in accordance with IFRS. Definitions and reconciliations of non -IFRS measures to the most directly comparable IFRS measure s are

included below.

7

DEFINITIONS

The Company defines its non-IFRS measures as follows:

Non-IFRS

measure

Definition Most directly comparable IFRS

measure

Why the Company uses the

measure

EBITDA Earnings before interest, taxes,

depreciation, depletion and

amortization

Net income (loss) and operating income

(loss)

EBITDA is a valuable indicator of

the Company’s ability to generate

operating income

Adjusted EBITDA EBITDA adjusted for non -cash,

extraordinary, non-recurring and other

items unrelated to the Company’s core

operating activities

Net income (loss) and operating income

(loss)

Adjusted EBITDA is a valuable

indicator of the Company’s ability

to generate operating income

from its core operating activities

normalized to remove the impact

of non -cash, extraordinary and

non-recurring items. The

Company provides guidance on

Adjusted E BITDA as useful

supplemental information to

investors, analysts, lenders, and

others

Trailing 12

months Adjusted

EBITDA

Adjusted EBITDA for the current and

preceding three quarters

Net income (loss) and operating income

(loss) for the current and preceding three

quarters

The Company uses the trailing 12

months Adjusted EBITDA in the

calculation of the net leverage

ratio (non-IFRS measure)

Total capex Additions to property, plant, and

equipment and mineral properties

adjusted for additions to asset

retirement obligations, additions to

right-of-use assets and capitalized

interest

Additions to property, plant and

equipment and mineral properties

The Company uses total capex in

the calculation of total cash capex

(non-IFRS measure)

Maintenance

capex

Portion of total capex relating to the

maintenance of ongoing operations

Additions to property, plant and

equipment and mineral properties

Maintenance capex is a valuable

indicator of the Company’s

required capital expenditures to

sustain operations at existing

levels

Growth capex Portion of total capex relating to the

development of growth opportunities

Additions to property, plant and

equipment and mineral properties

Growth capex is a valuable

indicator of the Company’s capital

expenditures related to growth

opportunities.

Net debt Debt less cash and cash equivalents

plus deferred financing costs (does not

consider lease liabilities)

Current debt, long -term debt and cash

and cash equivalents

Net debt is a valuable indicator of

the Company’s net debt position

as it removes the impact of

deferring financing costs.

Net leverage ratio Net debt divided by trailing 12 months

Adjusted EBITDA

Current debt, long -term debt and cash

and cash equivalents; net income (loss)

and operating income (loss) for the

current and preceding three quarters

The Company’s net leverage ratio

is a valuable indicator of its ability

to service its debt from its core

operating activities.

Liquidity Cash and cash equivalents plus

undrawn committed borrowing

capacity

Cash and cash equivalents Liquidity is a valuable indicator of

the Company’s liquidity

Free cash flow Cash flows from operating activities,

which excludes payment of interest

expense, plus cash flows from

investing activities

Cash flows from operating activities and

cash flows from investing activities

Free cash flow is a valuable

indicator of the Company’s ability

to generate cash flows from

operations after giving effect to

required capital expenditures to

sustain operations at existing

levels. Free cash flow is a

valuable indicator of the

Company’s ca sh flow available

for debt service or to fund growth

opportunities. The Company

provides guidance on free cash

flow as useful supplemental

information to investors, analysts,

lenders, and others.

Corporate selling,

general and

administrative

expenses

Corporate selling, general and

administrative less share -based

payments expense.

Selling, general and administrative

expenses

The Company uses corporate

selling, general and

administrative expenses to

assess corporate performance.

8

EBITDA, ADJUSTED EBITDA AND TRAILING 12 MONTHS ADJUSTED EBITDA

For the three months ended December 31, 2024 and 2023

For the three months ended December 31, 2024, the Company had EBITDA and Adjusted EBITDA by segment as follows:

(in thousands of US Dollars) Conda Arraias

Development

and

exploration Corporate Total

Net income (loss) $ 34,081 $ 638 $ 19 $ (5,156 ) $ 29,582

Finance (income) expense, net 745 (117 ) — 2,212 2,840

Current and deferred income tax expense

(recovery) 6,153 — — (1,676 ) 4,477

Depreciation and depletion 7,439 731 — 80 8,250

EBITDA $ 48,418 $ 1,252 $ 19 $ (4,540 ) $ 45,149

Unrealized foreign exchange (gain) loss — 1,309 (268 ) — 1,041

Share-based payment expense — — — 640 640

Transaction costs — — — 134 134

Other (income) expense, net 265 (1,756 ) 1 (1 ) (1,491 )

Adjusted EBITDA $ 48,683 $ 805 $ (248 ) $ (3,767 ) $ 45,473

(in thousands of US Dollars) Conda Arraias

Development

and

exploration Corporate Total

Operating income (loss) $ 41,452 $ 74 $ (248 ) $ (4,623 ) $ 36,655

Depreciation and depletion 7,439 731 — 80 8,250

Realized foreign exchange gain (208 ) — — 2 (206 )

Share-based payment expense — — — 640 640

Transaction costs — — — 134 134

Adjusted EBITDA $ 48,683 $ 805 $ (248 ) $ (3,767 ) $ 45,473

For the three months ended December 31, 2023, the Company had EBITDA and Adjusted EBITDA by segment as follows:

(in thousands of US Dollars) Conda Arraias

Development

and

exploration Corporate Total

Net income (loss) $ 19,065 $ (65,126 ) $ (341 ) $ (2,221 ) $ (48,623 )

Finance (income) expense, net 1,827 (182 ) (1 ) 3,176 4,820

Current and deferred income tax expense

(recovery) 4,801 — — (5,394 ) (593 )

Depreciation and depletion 5,892 648 5 60 6,605

EBITDA $ 31,585 $ (64,660 ) $ (337 ) $ (4,379 ) (37,791 )

Unrealized foreign exchange (gain) loss — (157 ) 48 — (109 )

Share-based payment recovery — — — 492 492

Impairments — 66,000 — — 66,000

Transaction costs — — — 199 199

Other (income) expense, net 788 (71 ) 1 — 718

Adjusted EBITDA $ 32,373 $ 1,112 $ (288 ) $ (3,688 ) $ 29,509

(in thousands of US Dollars) Conda Arraias

Development

and

exploration Corporate Total

Operating income (loss) $ 26,476 $ (65,536 ) $ (293 ) $ (4,436 ) $ (43,789 )

Depreciation and depletion 5,892 648 5 60 6,605

Realized foreign exchange gain 5 — — (3 ) 2

Share-based payment recovery — — — 492 492

Impairments — 66,000 — — 66,000

Transaction costs — — — 199 199

Adjusted EBITDA $ 32,373 $ 1,112 $ (288 ) $ (3,688 ) $ 29,509